| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.696 | 289 | 0 | 0 | 0 | 302 | 7.923 | 12.388 | 12.230 | 11.531 |
| Total Income - EUR | 58.546 | 289 | 0 | 0 | 0 | 302 | 50.942 | 12.388 | 12.230 | 81.202 |
| Total Expenses - EUR | 54.286 | 213 | 82 | 64 | 24 | 1.164 | 36.771 | 4.831 | 11.285 | 65.625 |
| Gross Profit/Loss - EUR | 4.259 | 77 | -82 | -64 | -24 | -862 | 14.171 | 7.557 | 945 | 15.577 |
| Net Profit/Loss - EUR | 2.503 | 68 | -82 | -64 | -24 | -871 | 12.643 | 7.240 | 823 | 13.141 |
| Employees | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Diagen Set Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 62.727 | 60.489 | 102.020 | 152.023 | 98.414 |
| Current Assets | 4.239 | 563 | 278 | 209 | 181 | 1.641 | 51.448 | 9.517 | 8.053 | 69.643 |
| Inventories | 38 | 38 | 37 | 37 | 36 | 45 | 3.154 | 302 | 251 | 0 |
| Receivables | 3.627 | 9 | 3 | 3 | 3 | 511 | 688 | 6.829 | 2.618 | 3.287 |
| Cash | 574 | 516 | 237 | 169 | 142 | 1.085 | 47.606 | 2.386 | 5.183 | 6.396 |
| Shareholders Funds | 4.323 | 338 | 251 | 182 | 155 | -719 | 11.940 | 7.337 | 3.242 | 16.364 |
| Social Capital | 90 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 202 | 201 |
| Debts | 32 | 339 | 140 | 137 | 135 | 65.086 | 99.997 | 104.200 | 156.939 | 151.796 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6832 - 6832" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Diagen Set Srl